Searched for
LIRAFIT
Glenmark set to join peers in 'Semaglutide' pushGlenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalate...- Reduce Glenmark Pharmaceuticals, target price Rs 1,265: ICICI SecuritiesICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals with a target price of Rs 1,265. The current market price is Rs 1365.9...
- No revision, Glenmark Pharma sticking to full-year guidance: VS ManiVS Mani, CFO of Glenmark Pharma, discusses the company's strong performance in FY25 with an average of Rs 1,100 crore per quarter. Challeng...
- Glenmark launches antidiabetic drug in IndiaThe drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the compan...
Load More